57 results
Page 3 of 3
8-K
EX-99.1
3t4124pxjr0 xw
1 Mar 22
Xilio Therapeutics Reports Pipeline and Business Progress and Fourth Quarter and Full Year 2021 Financial Results
8:00am
8-K
EX-99.1
pr2 sderb2oz8uw8
6 Jan 22
Xilio Therapeutics Appoints Yuan Xu, Ph.D., to its Board of Directors
7:45am
10-Q
ew0 lo7bmwzw7b38
2 Dec 21
Quarterly report
4:15pm
8-K
EX-99.1
raa9gw5 no
2 Dec 21
Xilio Therapeutics Reports Pipeline and Business Progress and Third Quarter 2021 Financial Results
8:00am
424B4
glh93ddinzqg
22 Oct 21
Prospectus supplement with pricing info
4:02pm
S-1/A
waocn 7ui2rsaiwbij
18 Oct 21
IPO registration (amended)
6:04am
S-1
EX-10.12
vy5vvfu9nux t4wmchrf
1 Oct 21
IPO registration
4:49pm
S-1
EX-10.18
w6gz9v3y8h avlb
1 Oct 21
IPO registration
4:49pm
S-1
EX-10.11
j8uqeoj gdcl
1 Oct 21
IPO registration
4:49pm
S-1
EX-10.14
24oy71kcjwa3i5kq5a5
1 Oct 21
IPO registration
4:49pm
S-1
oswlow743bwaa4sir
1 Oct 21
IPO registration
4:49pm
DRS/A
ek5253e6
14 Sep 21
Draft registration statement (amended)
12:00am
DRS
EX-10.11
snt9yik9
24 May 21
Draft registration statement
12:00am
DRS
EX-10.10
mwu90 1my
24 May 21
Draft registration statement
12:00am
DRS
ys9zak p9r
24 May 21
Draft registration statement
12:00am
DRS
EX-10.13
0xbza6ck50
24 May 21
Draft registration statement
12:00am
DRS
EX-10.17
lmufuc60
24 May 21
Draft registration statement
12:00am